We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 17, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Semiconductor wafer with high thermal conductivity
HYDROGEN STORAGE BY REVERSIBLE HYDROGENATION OF PI-CONJUGATED SUBSTRATES
INHIBITOR OF HMGB PROTEIN-MEDIATED IMMUNE RESPONSE ACTIVATION
METHODS AND SYSTEMS FOR DESIGNING PHOTOVOLTAIC SYSTEMS
SILK PERFORMANCE APPAREL AND PRODUCTS AND METHODS OF PREPARING THE SAME
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LACTATE METAL SALT
INDUCED EXPRESSION OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) FOR TREATMENT OF NEUROMUSCULAR, NEURODEGENERATIVE, AUTOIMMUNE, DEVELOPMENTAL AND/OR METABOLIC DISEASES